Mazen Noureddin, MD, MHSc joins HepaTx's Scientific Advisory Board
/PRNewswire/ -- HepaTx, a preclinical-stage biotechnology company developing cell therapies for liver diseases, announced today that Mazen Noureddin, MD, MHSc,...
Stay updated with breaking news from Fatty Liver Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- HepaTx, a preclinical-stage biotechnology company developing cell therapies for liver diseases, announced today that Mazen Noureddin, MD, MHSc,...
Exercise training can improve histologic response and liver fibrosis in patients with NAFLD.
Exercise training can lead to a significant reduction in liver fat for patients with nonalcoholic fatty liver disease (NAFLD), which is a leading cause of liver disease worldwide, according to a new study published in the American Journal of Gastroenterology.
Study Conducted with Arizona Liver Health Met Primary Endpoint and Established Proof-of-Concept for Prescription Digital Therapy Platform to Improve Disease Biomarkers in NAFLD and NASH... | December 8, 2022